While HIV incidence has remained stable in the industrialized world, the virus is still transmitted in the Developing World.  The development of methods of prophylaxis are critical to disease containment, yet moving products into affected areas is not practical or affordable.  Dr. Evangelia Vamvaka was part of a team that placed anti-HIV proteins into rice.  The rice produced a transgenic protein that inhibited the virus, and did so with great efficacy in the presence of other compounds from the plant.  The rice can be ground to a powder and potentially be used as an HIV preventative wherever rice is grown. Co-hosted by Lethbridge Canada high school student Michelle Wu.The original paper in PNAS Follow Dr. Vamvaka on Twitter: @VamvakaEv# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.